Pyrimidine derivatives and processes for the preparation thereof
CA 2093203 C · Owner: Novartis Ag · Inventors: Zimmermann, Jurg
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
There are described N-phenyl-2-pyrimidine-amine derivatives of formula I wherein, R1 is pyrazinyl, 1-methyl-1H pyrrolyl amino- or amino-lower alkyl-substituted phenyl wherein the amino group in each cast is free alkylated or acylated, 1H-indolyl or 1H-imidazolyl bonded at a five-membered ring carbon atom or, unsubstitut ed or lower alkyl-substituted pyridyl bonded at a ring carbon atom and, unsubstituted or substituted at the nitrogen atom by oxygen R2 and R3 are each independently of the other hydrogen or lower alkyl one or two of the radicals R4, R5, R6, R7 and R8 are each nitro fluoro-, substituted lower , alkoxy or a radical of formula II -N(R9)-C(=X)-(Y)n-R10 (II), wherein, R9 is …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 1, 1993 and granted November 26, 2002. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 1, 2013.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 1, 2015.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.